
About Biolan
Biolan is an Agriculture company based in Zamudio (Spain) founded in 2006. Biolan is engaged in developing biosensors for food safety and health diagnostics. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Biolan has completed 1 acquisition, including DNA Data. Biolan offers products and services including BIOFISH 7000 TMA, BIOMEAT 7000 NO2β, and BIOMILK 7000 SAL. Its focus areas include Technology, Biotechnology, Food Safety Diagnostics and Healthcare.
Company details
Biolan is involved in the development, manufacturing, and commercialization of biosensors, including enzymatic biosensors, potentiometric sensors, immunochromatographic tests, and genetic diagnostics. These solutions are utilized for detecting parameters related to food quality and safety, as well as health monitoring. The company serves sectors such as fisheries, meat, and dairy industries with innovative tools like BIOFISH 7000 TMA for fish freshness analysis, BIOMEAT 7000 NO2 for nitrite control, and BIOMILK 7000 SAL for sodium measurement. Additionally, Biolan is focused on sustainable and digitalized technologies to address specific industry needs and improve diagnostic precision.
- Latest Funding Round$200.88K (USD), Grant
Oct 2021
- InvestorsEuropean Union
& 2 more
- Investments & Acquisitions
Products & Services of Biolan
Biolan offers a comprehensive portfolio of products and services, including BIOFISH 7000 TMA, BIOMEAT 7000 NO2−, and BIOMILK 7000 SAL.
Device for measuring fish freshness in various matrices.
Tool for nitrite analysis in food industry products.
Equipment for sodium control in dairy industry products.
Apps and channels of Biolan
its YouTube channel Biolan Mb has 89 subscribers and 10 videos.
Videos from Biolan
The most watched videos on Biolan's YouTube channel, Biolan Mb (89 subscribers). Click a video to play it here.
More on Biolan Mb.
Funding Insights of Biolan
- Total Rounds 11
- Last Round Grant β $200,884
- Investors Count 3
Latest 10 of 11 funding rounds of Biolan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $200,884 | Grant | β | β | |
| May 2020 | $188,567 | Grant | β | β | |
| Jun 2019 | $113,454 | Grant | β | β | |
| May 2019 | $193,692 | Grant | β | β | |
| Jan 2018 | $339,533 | Grant | β | β | |
| Sep 2017 | $107,922 | Grant | β | β | |
| Jun 2017 | $848,356 | Grant | β | β | |
| Jul 2015 | $820,710 | Grant | β | β | |
| Feb 2015 | $56,042 | Grant | β | β | |
| Oct 2014 | $63,090 | Grant | β | β |
3 investors in total: 3 institutional.
Investors in Biolan
Biolan has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EIC Fund and Kereon Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
| kereon.es | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Biolan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biolan
Biolan has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DNA Data.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Genetic and biological analyses are provided for diagnosing genetic diseases. | dnadata.es | San Sebastian, Spain | 2012 | Feb 2023 | β’β’β’β’ |
Complete acquisition details for Biolan
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biolan
4 dated milestones of Biolan across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Biolan is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $201K.
- Acquisition Acquires DNA Data.
Web traffic of Biolan
The website of Biolan (biolanmb.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 12.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biolan
Complete news archive for Biolan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolan
Biolan was founded in 2006 and raised its 1st funding round 6 years after it was founded.
Biolan is headquartered in Zamudio, Spain. It is registered at Zamudio, Bizkaia, Spain.
Biolan is involved in the development, manufacturing, and commercialization of biosensors, including enzymatic biosensors, potentiometric sensors, immunochromatographic tests, and genetic diagnostics. These solutions are utilized for detecting parameters related to food quality and safety, as well as health monitoring. The company serves sectors such as fisheries, meat, and dairy industries with innovative tools like BIOFISH 7000 TMA for fish freshness analysis, BIOMEAT 7000 NO2 for nitrite control, and BIOMILK 7000 SAL for sodium measurement. Additionally, Biolan is focused on sustainable and digitalized technologies to address specific industry needs and improve diagnostic precision.
Biolan offers BIOFISH 7000 TMA, BIOMEAT 7000 NO2β, and BIOMILK 7000 SAL.
Biolan has made 1 acquisition, including DNA Data.
Biolan has 3 investors. Key investors include European Union, EIC Fund, and Kereon Partners.
